Understanding the Unique Harm to Patients in Recovery
Opioid use disorder is a chronic brain disorder, not a character defect. People who use Suboxone as part of their recovery are doing exactly what evidence-based medicine recommends — they are managing a medical condition under a physician's supervision. The profound injustice of Suboxone dental injury litigation is that these patients, many of whom worked incredibly hard to stabilize their health and rebuild their lives, were physically harmed by the very medication they took in good faith to get better. They did nothing wrong.
Yet the dental harm they sustained can compound stigma they already face. In some communities, visible tooth decay or tooth loss is unfairly associated with active drug use — a stereotype that ignores the many causes of dental disease and that is, in this case, a product of inadequately labeled pharmaceutical treatment rather than anything the patient did. People with Suboxone-related tooth loss have reported job discrimination, social withdrawal, difficulty in professional settings where appearance matters, and profound effects on self-esteem and relationships. These experiences are real, documented, and legally compensable.
How These Harms Are Documented and Compensated
In Suboxone dental injury litigation, non-economic damages for the psychological and social impacts of tooth loss are documented through mental health treatment records, sworn testimony describing the functional and emotional impact of tooth loss, statements from family members or co-workers, employment records showing changes after tooth loss, and expert testimony from psychologists or psychiatrists who can articulate the medical basis for emotional distress claims. Attorneys representing MAT patients approach this evidence with a framework that centers the patient's full humanity — their recovery journey, their responsibilities, and the additional burden placed on them by Indivior's failure to warn.
Frequently Asked Questions
Related Pages
Suboxone Dental Damage Explained
Suboxone sublingual film strips damage teeth through a chemical acid erosion mechanism. Citric acid in the film creates a highly acidic oral environment during dissolution, dissolving tooth enamel with repeated daily exposure. This process is distinct from ordinary tooth decay and produces a characteristic pattern of rapid, widespread, smooth-surface erosion that dentists can document in dental records.
Suboxone Statute of Limitations by State
Suboxone dental injury claims are subject to state product liability statutes of limitations, typically 2 to 3 years, which may run from the January 12, 2022 FDA safety communication under the discovery rule. Deadlines vary significantly by state and individual circumstances — time is critical and consultation with an attorney is the only reliable way to determine your specific deadline.
Suboxone Dental Records and Evidence Gathering
Dental records — including clinical notes, X-rays, and billing documentation — are the evidentiary foundation of every Suboxone dental injury claim. Gathering them promptly is critical because dental practices have limited record retention requirements and older records may be unavailable from closed or sold practices.
Suboxone Settlement Amounts and Expectations
Reported Suboxone dental injury settlements have ranged from approximately $35,000 for minor-to-moderate cases to $250,000 or more for complete tooth loss requiring full-mouth reconstruction. The MDL is ongoing and no global settlement has been announced — individual case values depend heavily on injury severity, documentation quality, and state-specific legal factors.
Indivior's Failure to Warn
Indivior, the manufacturer of Suboxone, had access to medical literature and adverse event data establishing the dental risk of its sublingual film formulation for years before adding dental warnings to its label. Under pharmaceutical product liability law, this gap between knowledge and disclosure forms the foundation of the failure-to-warn claims at the center of Suboxone dental injury litigation.
The FDA Suboxone Dental Warning — January 2022
On January 12, 2022, the FDA issued a formal drug safety communication confirming that buprenorphine medicines dissolved in the mouth — including Suboxone film — can cause severe dental problems. The FDA reviewed 305 adverse event reports and found widespread, serious dental injuries requiring extractions, root canals, and full reconstruction. This communication is legally significant as the potential trigger date for the statute of limitations under the discovery rule for thousands of patients.
Suboxone Dental Injury Qualification Criteria
Not every Suboxone user who experienced dental problems has a viable legal claim. Qualifying cases generally involve significant dental injuries — multiple cavities, extractions, tooth loss, or reconstruction — developed during Suboxone use, documented in dental records, and timely filed. Understanding the criteria helps patients determine whether to pursue a claim.
Suboxone vs. Generic Buprenorphine Film
The dental injury risk from buprenorphine sublingual film is not unique to the Suboxone brand — generic buprenorphine/naloxone sublingual films share the same acidic excipient mechanism and the same dental injury profile. However, pursuing claims against generic manufacturers involves different legal considerations than brand-name product liability claims under both federal and state law.
Suboxone Dental Treatment Costs
Dental rehabilitation costs for Suboxone-related injuries can range from several thousand dollars for restorations to $80,000 or more for full-mouth implant-supported reconstruction. These documented costs form the economic damages component of a claim and are recoverable in litigation. Understanding the cost breakdown helps patients evaluate the potential value of their claim.
How to File a Suboxone Dental Injury Lawsuit
Filing a Suboxone dental injury lawsuit begins with gathering dental and prescription records, consulting a pharmaceutical litigation attorney, and submitting a complaint. Most cases are filed in or transferred to MDL 3092 in the Northern District of Ohio. The process is handled almost entirely by the attorney, with no upfront costs under a contingency fee arrangement.
Suboxone Class Action vs. Individual Claims
Suboxone dental injury litigation is structured as a multidistrict litigation (MDL), not a class action. In an MDL, plaintiffs retain individual claims and individual damages — each client's recovery is based on their specific injuries, not shared with others. Understanding this distinction helps plaintiffs know what to expect from the process.
Suboxone Tooth Decay Lawsuit
Suboxone sublingual film strips — a medication-assisted treatment (MAT) for opioid use disorder — dissolve under the tongue and contain citric acid and other acidic excipients that, with repeated use, erode tooth enamel and cause rapid, severe dental decay. Thousands of patients who faithfully took Suboxone as prescribed to manage opioid dependence later discovered they had lost multiple teeth, required extensive dental reconstruction, or faced thousands of dollars in oral surgery costs — through no fault of their own. Manufacturer Indivior (formerly part of Reckitt Benckiser) knew or should have known about these dental risks for years but failed to include adequate warnings on the product label. The FDA confirmed the danger with a formal safety communication on January 12, 2022, requiring updated product labeling. Patients who suffered dental injuries while using Suboxone sublingual film may have valid product liability claims against Indivior for failure to warn.
View full case overview